http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102042296-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102042296-B1 |
| titleOfInvention | Novel bicyclic thiazole compounds |
| abstract | The present invention relates to novel bicyclic thiazole compounds that inhibit Traf2- and Nck-interacting kinases (TNIK), which are cancer patients, especially solid cancer patients, such as colorectal cancer, pancreatic cancer, non-small cell lung cancer, prostate cancer or breast cancer. Useful as a TNIK inhibitor administered to a patient. A bicyclic thiazole compound is a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof. <Formula I> (Wherein R 1 , R 2 , R 3 and Q are as defined in the specification) |
| priorityDate | 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.